The relationship between early insulin release and glucose tolerance in healthy subjects.

Sulphonylureas improve glucose tolerance by stimulating insulin secretion. Whether improved glucose tolerance results from enhanced early insulin release or greater total insulin secretion is not clear. Therefore insulin and C-peptide responses to oral glucose were measured in healthy subjects with and without a single dose of oral and intravenous glipizide. The intravenous glipizide administration caused a marked early insulin response, whereas oral glipizide administration resulted in greater total and peak insulin concentration. Oral glipizide did not reduce plasma glucose until 45 min of the glucose load. In contrast, enhancement of the early insulin response with intravenous glipizide almost completely prevented postprandial glucose rise. In conclusion, early insulin release is a major factor determining oral glucose tolerance in healthy subjects.

[1]  P. Savage,et al.  Hyperinsulinemia and Hypoinsulinemia: Insulin Responses to Oral Carbohydrate Over a Wide Spectrum of Glucose Tolerance , 1975, Diabetes.

[2]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[3]  L. Groop,et al.  Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects , 1987, Diabetes.

[4]  D. Kipnis,et al.  Plasma Insulin Responses to Glucose and Tolbutamide of Normal Weight and Obese Diabetic and Nondiabetic Subjects , 1966, Diabetes.

[5]  A. Melander,et al.  Bioavailability, Pharmacokinetics and Effects of Glipizide in Type 2 Diabetics , 1982, Clinical pharmacokinetics.

[6]  L. Groop,et al.  Comparison of Pharmacokinetics, Metabolic Effects and Mechanisms of Action of Glyburide and Glipizide During Long-Term Treatment , 1987, Diabetes Care.

[7]  G. Grodsky,et al.  Early Phase of Insulin Release , 1968, Diabetes.

[8]  M. Hulse,et al.  Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect. , 1973, Metabolism: clinical and experimental.

[9]  A. Melander,et al.  Efficacy of Dietary Regulation in Primary Health Care Patients with Hyperglycaemia Detected by Screening , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[10]  J. Halter,et al.  Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. , 1982, The Journal of clinical endocrinology and metabolism.

[11]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[12]  J. Olefsky,et al.  Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.

[13]  A. Melander,et al.  High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. , 1979, Journal of chromatography.